Rowlandmiller & Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-479
Closed -$103K 178
2024
Q1
$103K Sell
479
-65
-12% -$14K 0.02% 180
2023
Q4
$141K Hold
544
0.03% 155
2023
Q3
$140K Hold
544
0.03% 150
2023
Q2
$155K Sell
544
-92
-14% -$26.2K 0.04% 149
2023
Q1
$177K Sell
636
-260
-29% -$72.3K 0.04% 142
2022
Q4
$244K Hold
896
0.06% 135
2022
Q3
$239K Hold
896
0.06% 132
2022
Q2
$183K Hold
896
0.05% 142
2022
Q1
$189K Hold
896
0.04% 141
2021
Q4
$215K Buy
896
+230
+35% +$55.2K 0.05% 139
2021
Q3
$178K Sell
666
-230
-26% -$61.5K 0.06% 124
2021
Q2
$310K Buy
896
+110
+14% +$38.1K 0.08% 119
2021
Q1
$220K Hold
786
0.06% 134
2020
Q4
$192K Buy
786
+120
+18% +$29.4K 0.05% 134
2020
Q3
$211K Hold
666
0.08% 107
2020
Q2
$178K Hold
666
0.06% 124
2020
Q1
$211K Buy
666
+5
+0.8% +$1.58K 0.08% 107
2019
Q4
$196K Hold
661
0.06% 124
2019
Q3
$154K Hold
661
0.05% 123
2019
Q2
$155K Buy
661
+125
+23% +$29.2K 0.05% 124
2019
Q1
$127K Hold
536
0.05% 128
2018
Q4
$161K Buy
536
+30
+6% +$9.03K 0.07% 111
2018
Q3
$179K Hold
506
0.06% 115
2018
Q2
$147K Hold
506
0.06% 119
2018
Q1
$139K Hold
506
0.06% 119
2017
Q4
$162K Sell
506
-1,544
-75% -$495K 0.06% 111
2017
Q3
$375K Buy
2,050
+1,544
+305% +$283K 0.16% 78
2017
Q2
$137K Hold
506
0.06% 115
2017
Q1
$138K Hold
506
0.06% 114
2016
Q4
$144K Hold
506
0.07% 108
2016
Q3
$158K Hold
506
0.07% 105
2016
Q2
$123K Buy
+506
New +$123K 0.06% 113
2016
Q1
Sell
-376
Closed -$111K 124
2015
Q4
$111K Hold
376
0.06% 121
2015
Q3
$110K Hold
376
0.06% 118
2015
Q2
$152K Hold
376
0.08% 110
2015
Q1
$155K Hold
376
0.08% 105
2014
Q4
$128K Buy
+376
New +$128K 0.06% 111